Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Car T Cells: Living Hiv Drugs Publisher Pubmed



Namdari H1 ; Rezaei F2 ; Teymoorirad M2 ; Mortezagholi S3 ; Sadeghi A1 ; Akbari A4
Authors

Source: Reviews in Medical Virology Published:2020


Abstract

Human immunodeficiency virus type 1 (HIV-1), the virus that causes AIDS (acquired immunodeficiency syndrome), is a major global public health issue. Although the advent of combined antiretroviral therapy (ART) has made significant progress in inhibiting HIV replication in patients, HIV-infected cells remain the principal cellular reservoir of HIV, this allows HIV to rebound immediately upon stopping ART, which is considered the major obstacle to curing HIV infection. Chimeric antigen receptor (CAR) cell therapy has provided new opportunities for HIV treatment. Engineering T cells or hematopoietic stem cells (HSCs) to generate CAR T cells is a rapidly growing approach to develop an efficient immune cell to fight HIV. Herein, we review preclinical and clinical data available for the development of CAR T cells. Further, the advantages and disadvantages of clinical application of anti-HIV CAR T cells will be discussed. © 2020 John Wiley & Sons, Ltd
Related Docs
View other Related Docs
1. Therapeutic Roles of Car T Cells in Infectious Diseases: Clinical Lessons Learnt From Cancer, Reviews in Medical Virology (2022)
2. The Efficacy of Chimeric Antigen Therapy in Viral Infectious Diseases: A Systematic Review of Randomized Controlled Trials, Turkish Journal of Immunology (2024)
3. Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells, Frontiers in Immunology (2018)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (2)
Amir Ali Hamidieh (2)
Other Related Docs
4. The Role of Latency Reversal Agents in the Cure of Hiv: A Review of Current Data, Immunology Letters (2018)
5. A Vhh-Based Anti-Muc1 Chimeric Antigen Receptor for Specific Retargeting of Human Primary T Cells to Muc1-Positive Cancer Cells, Cell Journal (2021)
6. Chimeric Antigen Receptor-Natural Killer Cells: A Promising Sword Against Insidious Tumor Cells, Human Cell (2023)
7. Chimeric Antigen Receptor -T Cell Therapy: Applications and Challenges in Treatment of Allergy and Asthma, Biomedicine and Pharmacotherapy (2020)
8. The Current Landscape of Car T-Cell Therapy for Solid Tumors: Mechanisms, Research Progress, Challenges, and Counterstrategies, Frontiers in Immunology (2023)
9. Chimeric Antigen Receptor T-Cell Therapy for Breast Cancer, Future Oncology (2021)
10. Autoimmunity As a Target for Chimeric Immune Receptor Therapy: A New Vision to Therapeutic Potential, Blood Reviews (2020)
11. Solid Tumors Challenges and New Insights of Car T Cell Engineering, Stem Cell Reviews and Reports (2019)
12. Programmable and Multi-Targeted Cars: A New Breakthrough in Cancer Car-T Cell Therapy, Clinical and Translational Oncology (2021)
13. Production of Car T-Cells by Gmp-Grade Lentiviral Vectors: Latest Advances and Future Prospects, Critical Reviews in Clinical Laboratory Sciences (2019)
14. Novel Car T Therapy Is a Ray of Hope in the Treatment of Seriously Ill Aml Patients, Stem Cell Research and Therapy (2021)
15. Car-Modified T-Cell Therapy for Cancer: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
16. Strategies to Eradicate Hiv From Infected Patients: Elimination of Latent Provirus Reservoirs, Cellular and Molecular Life Sciences (2019)
17. Cancer Stem Cell-Targeted Chimeric Antigen Receptor (Car)-T Cell Therapy: Challenges and Prospects, Acta Pharmaceutica Sinica B (2021)
18. Effect of Anti-Cd3/Cd28 Dynabeads and Allogeneic Pbmcs on Expansion of Anti-Muc1 Chimeric Receptor T Cells, Journal of Mazandaran University of Medical Sciences (2022)
19. Car T Cell Therapy in Solid Tumors; With an Extensive Focus on Obstacles and Strategies to Overcome the Challenges, International Immunopharmacology (2021)
20. Chimeric Antigen Receptor T-Cell Therapy for Melanoma, Expert Review of Clinical Immunology (2021)